Recent reports highlight serious illnesses and deaths linked to contaminated ColdRif cough syrups in India, primarily due to toxic industrial chemicals like diethylene glycol. Investigations reveal specific batches were affected, prompting bans and nationwide testing to ensure public safety and prevent future tragedies.
Related Posts
No cashless claim for Tata AIG health insurance policyholders in Max Hospitals, becomes 3rd insurer to do so
Post Views: 11 Tata AIG suspended cashless services at Max…
Cough syrup not faulty, pharma firm’s 19 drugs banned as precaution: Rajasthan health minister
Post Views: 15 “We got the medicine checked twice. First…
India’s healthcare future hinges on data: Experts call for curation, sharing, and AI adoption
Post Views: 12 At a high-powered panel on future technologies,…